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subtypes and may also prevent the propagation of potential pandemic viruses by fighting against emerging strands. Here we
propose a computational framework to study structural binding patterns and detailed molecular mechanisms of viral surface
glycoprotein hemagglutinin (HA) binding with a broad spectrum of neutralizing monoclonal antibody fragments (Fab). We
used rigorous free-energy perturbation (FEP) methods to calculate the antigen-antibody binding affinities, with an aggregate
underlying molecular-dynamics simulation time of several microseconds (~2 ms) using all-atom, explicit-solvent models. We
achieved a high accuracy in the validation of our FEP protocol against a series of known binding affinities for this complex
system, with<0.5 kcal/mol errors on average. We then introduced what to our knowledge are novel mutations into the interfacial
region to further study the binding mechanism. We found that the stacking interaction between Trp-21 in HA2 and Phe-55 in the
CDR-H2 of Fab is crucial to the antibody-antigen association. A single mutation of either W21A or F55A can cause a binding
affinity decrease of DDG > 4.0 kcal/mol (equivalent to an ~1000-fold increase in the dissociation constant Kd). Moreover, for
group 1 HA subtypes (which include both the H1N1 swine flu and the H5N1 bird flu), the relative binding affinities change
only slightly (< 51 kcal/mol) when nonpolar residues at the aA helix of HA mutate to conservative amino acids of similar
size, which explains the broad neutralization capability of antibodies such as F10 and CR6261. Finally, we found that the
hydrogen-bonding network between His-38 (in HA1) and Ser-30/Gln-64 (in Fab) is important for preserving the strong binding
of Fab against group 1 HAs, whereas the lack of such hydrogen bonds with Asn-38 in most group 2 HAs may be responsible for
the escape of antibody neutralization. These large-scale simulations may provide new insight into the antigen-antibody binding
mechanism at the atomic level, which could be essential for designing more-effective vaccines for influenza.INTRODUCTIONInfluenza A virus is one of the most fatal infectious diseases
in humans and poultry (1,2). Each year, this virus causes
hundreds of thousands of deaths in humans and tens of
millions of deaths in birds worldwide (3–9). The recent
H1N1 swine flu pandemic and the spread of highly patho-
genic H5N1 avian flu caused a great public-health concern
(10–18). Current vaccines usually respond to a limited
number of strains and often fail to neutralize emerging new
strains because of rapid genetic evolution (19–24). Although
some neuraminidase (NA) inhibitors, such as oseltamivir
(Tamiflu) and zanamivir (Relenza), have shown effective
suppression against influenza viruses, their efficacy is often
challenged by increasing drug resistance (25–32).
Therefore, broad and potent cross-protective host immu-
nity is in great demand for influenza prevention and treat-
ment. High-affinity neutralizing antibodies (nAbs), such as
F10 and CR6261, have been selected by phage display on
recombinant H5 HA (13–15). Both F10 and CR6261 have
shown broad neutralization to all group 1 subtypes,
including the H1N1 Spanish flu and the H5N1 bird flu. In
general, 16 hemagglutinin (HA) subtypes of influenza A
viruses are categorized into two major phylogenetic groups:Submitted September 29, 2011, and accepted for publication January 27,
2012.
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and group 2 (H3, H4, H7, H10, H14, and H15). The cocrys-
tal structures of H5 HAwith antibodies reveal that both anti-
bodies can block the viral infection by inserting their heavy
chain into a conserved helical stem region in HA1 and HA2,
thereby possibly preventing membrane fusion (13–15). We
believe that the similar neutralization effect of these nAbs
could result from some important common features that
are critical for developing new broad-spectrum vaccines.
However, several underlying key mechanisms remain
unclear, and it remains to be determined at which molecular
level antibodies have a broad range of neutralization, and
why most group 2 influenza viruses (e.g., H3 and H7) cannot
be neutralized by F10 or CR6261. To address these issues,
we performed large-scale, free-energy perturbation (FEP)
simulations to characterize key residues and their mutation
effects on HA-Fab binding at the atomic level. The FEP
method has been widely used to calculate binding affinities
for a variety of chemical and biological systems, such as
solvation free-energy calculation, ligand-receptor binding,
protein–protein interaction, and protein-DNA (RNA)
binding (17,18,33–44), and is often regarded as the most
rigorous and reliable method for free-energy calculations.
Many previous FEP calculations achieved high accuracy
for various protein-protein and protein-ligand binding affin-
ities when compared with experiments (37,45–47). Ourdoi: 10.1016/j.bpj.2012.01.043
1454 Xia et al.previous work on H3N2 HA-antibody and H5N1 HA-
receptor binding systems also showed excellent agreement
between the calculated binding free energies and experi-
mental values (17,18). Among several available computa-
tional methods developed in past years, the FEP method
based on the all-atom explicit-solvent model is probably
the most accurate approach for estimating the relative
antigen-antibody binding affinity (45,46). In this study, we
first validated our FEP protocol by comparing the simulated
binding affinity changes with available experimental data.
We then extended our FEP calculation to novel (to our
knowledge) mutations at the interfacial region on either
group 1 HA or monoclonal antibody fragment (Fab). We
found that the stacking interaction is critical for HA-anti-
body recognition, and the nonspecific hydrophobic interac-
tion is responsible for the broad neutralization of antibody.
To understand why F10-like antibodies successfully
neutralize most group 1 influenza subtypes but fail in group
2 subtypes, we further investigated the role of a highly
conserved His residue observed in almost all important
group 1 HA subtypes (e.g., H1 and H5) by mutating it to
Asn in four of the six group 2 HA subtypes (i.e., H3, H7,
H10, and H15). Our results show that such a computational
approach can serve as a complementary tool for interpreting
and predicting critical mutations for HA-antibody binding.METHOD AND SYSTEM
Molecular systems
The H5 HA (Viet04/H5) with Fab F10 complex (PDB entry 3FKU) was
used for antigen-antibody binding, where the HA (HA1 and HA2) monomer
was bound to one Fab with both heavy and light chains (13). The HA-Fab
complex was solvated in a 71.5 A˚  81.5 A˚  160.0 A˚water box, and then
seven sodium ions were added to neutralize the system, with a total number
of ~88,000 atoms. The solvated system was first energy-minimized by
20,000 steps, followed by a 500,000-step equilibration. The snapshot during
the equilibration was randomly picked as the starting point for the FEP
calculations. The unbound (free) state was modeled with the HA or F10
only, solvated in water, and equilibrated with a similar process. The
particle-mesh Ewald method was used for the long-range electrostatic inter-
actions with a cutoff distance of 12 A˚ (48). All underlying molecular-
dynamics simulations, which are widely used to simulate biological
systems (49–58), were performed using the NAMD2 (59) molecular
modeling package with a 1.5 fs time step in the NPT ensemble at 1 atm
and 300 K. The CHARMM22 force field (60) and TIP3P water model
(61) were used.FEP protocol
When an antigenic variation occurs, the change in the HA binding affinity
to a neutralizing antibody can be calculated by the FEP method (17,18,33–
35,37–40). The Helmholtz free energy of a system can be expressed as
G ¼ kT ln Z ¼ kT ln
ZZ
dpdq exp½  bHðp; qÞ

; (1)
where Z is the partition function; H (p,q) is the Hamiltonian of the system;
p and q represent the momentum and the coordinate, respectively; k is theBiophysical Journal 102(6) 1453–1461Boltzmann constant; T is the temperature; and b is equal to 1/kT. The
binding free-energy change DG due to a mutation in HA or antibody can
then be calculated as
DGl ¼ kT lnhexpð  b½Vðlþ DlÞ  VðlÞÞil (2)
DG ¼
X
DG ; (3)
l
l
where V(l) ¼ (1  l) V1 þ l V2, with V1 representing the potential energy
of the wild-type (WT) and V2 representing the potential energy of the
mutant. The FEP parameter l changes from 0 (V1) to 1 (V2) when the system
changes from the WT to the mutant, and <.>l represents the ensemble
average at potential V(l). In typical FEP calculations, to ensure a smooth
transition from state A to state B, many perturbation windows have to be
used. To avoid singularity at small interaction distances, when l approaches
0 or 1 (a situation often referred to as endpoint-catastrophe), we used soft-
core potentials for the Lennard-Jones interactions, with the 12-6 LJ function
modified as follows (62,63):
VvdW ¼ εij
" 
R2ij
r2ij þ dð1 lÞ
!6

 
R2ij
r2ij þ dð1 lÞ
!3#
; (4)
where εij is the depth of the potential well, Rij is the radius, rij is the distance
between a pair of atoms, and d is the shift parameter that allows a smooth
transition from the original Lennard-Jones potential to zero or vice versa.
The electrostatic interactions are handled with the normal Coulomb law
but are switched on for the appearing atoms only after l > 0.1, thus
allowing the soft-core Lennard-Jones potentials to repel the possible over-
lapping before introducing the electrostatic interactions. Similarly, for the
disappearing atoms, the electrostatic interactions are switched off after
l > (1  0.1) ¼ 0.9.
In general, it is difficult to directly calculate the absolute binding affinity
change DGA for the binding process between a viral surface protein and an
antibody due to the long timescale and complicated binding process.
However, we can avoid this problem by designing a thermodynamic cycle
to calculate the relative binding free-energy change, i.e., DDGAB. Instead of
calculating the difficult direct binding energies DGA and DGB, we calculate
the free-energy changes for the same mutation in both the bound state (HA
bound to antibody, DG1) and the free state (HA or antibody not bounded,
DG2). Within a complete thermodynamic cycle, the total free-energy
change should be zero, which gives the relative binding affinity due to
the mutation from A/ B as:
DDGbind ¼ DGB  DGA ¼ DG1  DG2: (5)
In the current setup, we adopted a 20-window scheme with a soft-core
potential (l ¼ 0.00001, 0.0001, 0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5,
0.6, 0.7, 0.8, 0.9, 0.95, 0.99, 0.999, 0.9999, 0.99999, 1). For each mutation,
we performed at least five independent runs starting from different initial
configurations (taken from the equilibration) for better convergence. The
simulation time for each window was 0.3 ns. In each FEP l-window, the
first 4000 steps were for the further equilibration. Larger window sizes
and longer simulation durations were also tested in our previous studies,
and we found that the current setup gives us a reasonable convergence in
the final binding affinities. Therefore, at least 60 ns (20 windows 
0.3 ns 5 runs 2 states) of simulation timewere generated for each muta-
tion, and the total aggregate simulation time for this study was ~2 ms, which
is much longer than most FEP calculations currently reported in the
literature.
Despite the controversy in the literature about the meaningfulness of
breaking down the total free energy into components, and the ambiguity
associated with a path-dependent decomposition (64–67), we believe
a breakup of the total binding free energy into its van der Waals (vdW)
TABLE 1 Comparison of FEP simulation results with
experimental data for the HA-nAb binding free-energy change
due to the mutation in HA
Mutation
Calculated
DDG (kcal/mol) Reverse DDG (kcal/mol)
Experimental
DDG (kcal/mol)
Influenza HA Antibody Binding Affinity Calculation 1455and electrostatic components can provide useful information about the
underlying physical interactions involved in HA-Fab binding. In this study,
we collected the contributions of free-energy change by vdW and electro-
static interactions separately. Because of the nonlinearity of the FEP formu-
lation, there may be a small coupling term in this approach.N502A 0.285 0.28 0.115 0.48 (A502N) 0.4
V522L 0.575 0.60 0.205 1.15 (L522V) 0~0.5
V522A 0.915 0.29 1.085 0.59 (A522V) 1.3~1.6
V522E 9.625 0.93 8.225 1.61 (E522V) no bound states
observed
I562A 2.425 0.45 1.815 0.46 (A562I) N/A
Total of five independent runs were performed for both the bound and free
states for the standard error calculations, with each running 6 ns.RESULTS AND DISCUSSION
Validation of the FEP protocol with known
experimental data
Mutagenesis studies of the H5-F10 complex have shown the
importance of the binding region between the aA helix of
H5 and Fab, which was proposed to prevent the conforma-
tional change of aA helix and the subsequent membrane
fusion (13–15) (see Fig. 1). We noticed that some experi-
mental data are available for mutagenesis studies in the
aA helix region. Therefore, we first used these experimental
data to validate our FEP protocol by calculating the relative
binding free energies for mutations N502A, V522A, V522L,
and V522E in the aA helix (subscripts 1 and 2 refer to HA1
and HA2, respectively, and the residue numbering system
follows that of H3 (PDB entry: 2HMG)) (13).
The first target site, Asn-502, is exposed to the solvent in
the aA helix, and hence is not in direct contact with Fab.
Presumably, the mutation N502Awill not affect the binding
affinity significantly. Our simulations showed that the
N502A mutation enhanced the binding affinity slightly,
with DDG ¼ 0.28 5 0.28 kcal/mol (equivalent to an
~1.6-fold enhancement (decrease) in binding dissociation
constant Kd; see Table 1), which agreed well with an exper-
imental result of an ~2-fold enhancement in Kd for the same
mutation (13). For the second target site, Val-522, which
is conserved in group 1 HA as directly interacting with
the complementarity-determining region H1 (CDR-H1) ofFIGURE 1 Molecular modeling system for HA protein binding with the
antibody F10. (a) Overview of the HA-antibody complex structure. The HA
and nAb are represented by surface and cartoon; HA1 and HA2 are colored
blue and green, respectively, and both the heavy chain and light chain of the
antibody are colored cyan. (b) Detailed view of the antigen-antibody
binding interface, with the contact residues rendered with sticks. The total
size of simulation system is 88,345 atoms for WT.F10, we examined three different mutations: V522A,
V522L, and V522E. An experimental site-directed mutagen-
esis study of V522A revealed an ~10- to 20-fold increase in
Kd (13) (equivalent to a 1.3~1.6 kcal/mol decrease in
binding free energy), which was comparable to our FEP
result of DDG ¼ 0.91 5 0.29 kcal/mol (see Table 1).
However, a conservative mutation to Leu of similar size as
Val-522 had little influence on the binding affinity. We
observed only a slight reduction in the binding affinity
(DDG ¼ 0.575 0.60 kcal/mol), which was also consistent
with experiments in which the concentration of the bound
state was decreased by <10% (13). As one would expect
for the V522E mutation, the inclusion of charged amino
acid in the hydrophobic core at the binding interface
severely interfered with the antibody association with the
aA helix of HA, resulting in a significant decrease in
binding affinity, DDG ¼ 9.62 5 0.93 kcal/mol. The
V522E mutation on Fab F10 consistently failed to neutralize
the HA in experiment (Table 1) (13).
We further validated our FEP approach by performing
extra reverse FEP calculations in which five mutants (Ala-
502, Leu-522, Ala-522, Glu-522, and Ala-562) were mutated
back to their WTs (Asn-502, Val-522, Val-522, Val-522, and
Ile-562), respectively (Table 1). We found that all five back-
ward FEP simulations (mutants to WT) and forward FEP
calculations (WT to mutants) showed similar binding affin-
ities but with an opposite sign. The results of both methods
are in good agreement with experimental results. Consid-
ering the large size of the HA-Fab system, our FEP calcula-
tion provided a relatively small deviation of <0.5 kcal/mol
on average compared with available experimental data.
Therefore, the FEP simulation protocol may be employed
as a reliable tool for antigen-antibody complex binding
affinity studies.The stacking interaction and hydrophobic
environment are crucial for HA binding to CDR-H2
Inspired by encouraging results from the above validation
with known mutations, we extended our FEP method to
novel (to our knowledge) mutations found in either HA or
the Fab side at the binding interface. The cocrystalBiophysical Journal 102(6) 1453–1461
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suggest that the interactions between the aA helix of HA
and CDRs of the Fab may be important for neutralization
(13,14). As a key interaction site, we first focused on
Trp-212 and Ile-562, two conserved residues that are
observed in all subtypes of HAs, which make hydrophobic
interactions with Met-54 and Phe-55 in the CDR-H2 of
Fab F10 (equivalent to Ile-53 and Phe-54, respectively, in
antibody CR6261).
In addition to the general hydrophobic interaction,
a stacking interaction between the indole ring of Trp-212
and phenyl group of Phe-55 (or Phe-54) of Fab F10 (or
CR6261) is believed to play a critical role in binding recog-
nition between the aA helix of HA and the CDR-H2 of
Fab F10 (i.e., by providing the binding specificity). Here,
we performed computational mutagenesis for these sites to
evaluate how interactions associated with the aromatic
side chains (pp stacking) aid in the recognition of their
binding partners. We started by mutating Trp-212 to Ala
using our FEP simulation. Knocking out Trp-212 with
a smaller amino-acid Ala resulted in a binding affinity
decrease of DDG ¼ 4.02 5 0.34 kcal/mol, which corre-
sponds to an ~1000-fold increase in the dissociation
constant Kd. Similarly, a counter mutation on the antibody’s
Phe-55 with Ala reduced the binding affinity by DDG ¼
4.245 0.76 kcal/mol, implying that the stacking interaction
between two aromatic rings is indeed important, contrib-
uting ~4 kcal/mol to the binding affinity. The mutation
effect on the binding site structure is clearly depicted in
Fig. 2 for the WT and W212A at the end of simulation.
Due to the lack of an aromatic ring and a shorter side chain
in the mutant Ala-212, the intermolecular hydrophobic
cluster made of Trp-212, Phe-55, and Met-54 is largely dis-
rupted. On the other hand, we noticed enhancement of an
intramolecular interaction between Met-54 and Phe-55 in
CDR-H2 of Fab. A free-energy decomposition confirmed
the role of vdW interactions (see Method and System for
details). Almost all (98%) of the total contribution to the
binding affinity originated from the vdW interactionsFIGURE 2 Structural comparison of F10 nAb bound to H5 HA around
CDR-H2 due to the W212A mutation (HA, green; nAb, cyan). The overall
complex is represented as a cartoon and the residues at interaction face are
rendered with spheres. The interactions of Trp-212 (HA) with Met-54/Phe-
55 (nAbs) are largely diminished by W212A substitution.
Biophysical Journal 102(6) 1453–1461(4.11 kcal/mol), whereas the electrostatic interactions
played only a minor role (0.05 kcal/mol). The coupling
term was 0.04 kcal/mol. Note that our estimated stacking
interaction (~4 kcal/mol) and the vdW component of the
total free energy (4.11 kcal/mol) are very similar to the
previously reported value of stacking interactions between
two idealized benzene rings (4.08 kcal/mol) (68). Overall,
our energetic analysis confirmed that the large free-energy
loss in the W212A mutation is attributed to the destruction
of stacking interactions between two aromatic residues
from both HA and antibody. We further evaluated the
effect of hydrophobic interactions with two nonconservative
mutations: F55E (mutating to an acidic residue) and
F55K (mutating to a basic residue). Much larger binding
affinity decreases of 13.58 5 0.55 kcal/mol and 7.66 5
0.97 kcal/mol were found for F55E and F55K, respectively
(Table 2), which supports the notion that the recognition of
HA by nAb F10 is highly dependent on the hydrophobic
interactions at the binding interface.
Given the crucial role of the hydrophobic interactions
between these two aromatic residues (HA2’s Trp-21 and
F10’s Phe-55), we further investigated the nearby nonpolar
residue Met-54 in F10 (Ile-53 in CR6261), which displays
strong contacts with Trp-212 and Ile-452 in HA2, forming
a hydrophobic cluster. As expected, the nonconservative
M54E or M54K mutations broke the hydrophobic core and
caused ~10 kcal/mol free-energy decreases in our FEP simu-
lations (Table 2). However, substituting Met with Ile, as
found in Fab CR6261, or with Ala, was shown to destabilize
the protein association by DDG¼ 1.105 0.31 kcal/mol and
2.135 0.36 kcal/mol, respectively (Table 2). Note that the
free-energy decreases in conservative mutations of M54I
or M54A are smaller than those of aromatic residue dele-
tions in W212A or F55A. This indicates that the stacking
interaction between aromatic residues is more important
for the Fab F10 neutralization, even though a hydrophobic
environment around these key aromatic residues is still
required.
Overall, our FEP simulations revealed in detail the deter-
mining factors in the interaction between CDR-H2 of Fab
and HA. The stacking interactions between the aromatic
rings from both HA and Fab were essential for the antigen-
antibody binding. Preserving a hydrophobic environmentTABLE 2 FEP simulation results for the HA-nAb binding free-
energy change due to the mutation in HA2/CDR-H2
Mutation Calculated DDG (kcal/mol)
W212A 4.025 0.34
M54A 2.135 0.36
M54L 1.105 0.31
M54E 10.025 1.11
M54K 9.295 1.20
F55A 4.245 0.76
F55E 13.585 0.55
F55K 7.665 0.97
TABLE 3 FEP simulation results for the HA-nAb binding free-
energy change due to the mutation in HA/CDR-H1
Mutation Calculated DDG (kcal/mol)
Influenza HA Antibody Binding Affinity Calculation 1457around these key aromatic residueswas found to be important
as well, i.e., the existence of nonpolar residues, such as
Met-54 in F10 and Ile-53 in CR6261, also helped.H381N 1.325 0.78
V522A 0.915 0.29
V522I 1.085 0.59
V522L 0.575 0.60
V522F 1.445 0.87
V522E 10.435 0.83
V522D 15.475 1.09
V522R 13.455 0.98
V522K 7.285 1.51
I562A 2.425 0.45
I562V 0.485 0.46
I562L 0.845 0.50
I562E 2.245 1.59
I562K 0.385 0.65Nonspecific hydrophobic interactions are
responsible for the broad antibody neutralization
In addition to the hydrophobic interactions between HA and
CDR-H2, another hydrophobic core is formed in the aA
helix and the CDR-H1 (Fig. 3), where Pro-2931, Val-522,
and Ile-562 in HA are in contact with Val-27 and the methyl
group of Thr-28 in F10. We first investigated the role of Val-
522 using two types of FEP mutations: one with other
nonpolar residues to keep the hydrophobic environment
intact, and one with charged ones to break the hydrophobic
core. The FEP calculation results are listed in Table 3. In
general, for mutations to similarly sized hydrophobic resi-
dues, minor binding free-energy changes could be expected,
but for mutations to charged residues, significant decreases
in binding affinity or even disassociations of the HA-Fabs
complex could be expected. Indeed, our simulations showed
that the polarity of the substituted residue at site 52 of HA2 is
critical for preserving the WT binding affinity. Of more
interest, the conservative hydrophobic mutations displayed
more or less similar binding affinities, with an ~51 kcal/mol
variation (Table 3), indicating that the exact hydrophobic
residue type is less critical in this binding environment.
The mutations to charged amino acids, on the other hand,
clearly broke up the antigen-antibody association with a
high free-energy penalty of 7.28~15.47 kcal/mol (see
Table 3). It should be noted that V522I substitution couldFIGURE 3 Structural comparison of F10 nAb bound to H5 HA around
CDR-H2 due to I562A and I562K mutations (HA, green; nAb, cyan). The
overall complex is represented as cartoon and the residues at interaction
face are rendered with spheres. The hydrophobic core (shown in spheres)
is broken by the I562A mutation but is preserved in the I562K mutation.have even stronger binding with Fab than the WT, where
the binding affinity enhanced by DDG ¼ 1.08 5
0.59 kcal/mol, indicating that Fab is even more effective
for HAs that possess an I522 residue. It is interesting to
observe that Ile, Leu, and Val are the most common residue
types at site 52 of HA2 for all of the subtypes of group 1
HA: Ile and Leu are two dominant amino acids in subtype
H13/H16 and H12, respectively, whereas Val is the majority
amino acid in other subtypes of group 1 HAs (Table 4). Thus,
the strong binding affinity and the limited sequence diversity
(within aliphatic amino acids Ile, Leu, or Val) at site 52
explains why antibody F10 could have broad neutralization
toward various HAs.
In contrast to the mutational effect at Val-522, which
shows a clear binary dependence on residue polarity, the
nearby hydrophobic residue Ile-562 displayed a more
sophisticated pattern for the individual amino acid substitu-
tions. For example, similarly sized I562V and I562L
mutations showed similar binding activities as the WT,
within51 kcal/mol, whereas mutation to a smaller but still
hydrophobic Ala residue reduced the binding affinity by
~2.42 5 0.45 kcal/mol (Table 3). The free-energy decom-
position analysis revealed that most of the free-energy loss
(2.50 kcal/mol) was due to the weaker vdW interactions.
This is clearly shown in Fig. 3, where the hydrophobic inter-
action in the WT Ile-562 with Pro-2931 in HA1 and Val-27
of Fab has been weakened by the short side chain of Ala,
and the extra space is partially filled by two water molecules
making contact with Ala.
A more dramatic difference was observed in the I562K
mutation, where a nonconservative charged residue was
introduced; however, the binding affinity was not affected or
was slightly enhanced by DDG ¼ 0.38 5 0.65 kcal/mol.
Fig. 3 shows how the long side chain (also hydrophobic)
and positively charged NH3þ group of Lys could be packed
in the binding interface. The terminal amine group is pointing
out from the hydrophobic binding interface and interactswith
hydrophilic residues such as Asn-532 and Asn-602, whereasBiophysical Journal 102(6) 1453–1461
TABLE 4 Comparison of the sequence conservation among 16 HA subtypes
Group Cluster Subtype
HA1 HA2
17 18 38 40 18 19 20 21 38 41 42 44 45 46 48 49 52 53 55 56 111
Group 1 H1a H2 Y H H K V D G W K T Q A I D I T V N V I H
H5 Y H H Q V D G W Q T Q A I D V T V N I V H
H1 Y H H V V D G W K T Q A I D I T V N V I H
H6 Y H H V I D G W K T Q A I D I T V N I I H
H1b H13 Y L S I I N G W K T Q A I D I T I N I I H
H16 Y L S V I N G W K T Q A I D I T I N I I H
H11 Y L S V I N G W K T Q A I D I T V N I V H
H9 H8 Y Q Q M I D G W Q T Q A I D I T V N I I H
H12 Y Q Q E V A G W R T Q A I D M Q L N V I H
H9 Y Q H K V A G W R T Q A I D I T V N I V H
Group 2 H3 H4 H H T Q I D G W L T Q A I D I T L N L I T
H14 H H S K I D G W L T Q A I D I N L N L I T
H3 H H N T V D G W L T Q A I D I N L N V I T
H15 H15 H H N T I D G W Y T Q A I D I T L N L I A
H7 H H N T I D G W Y T Q A I D I T L N L I A
H10 H H N T V D G W Y T Q A I D I T L N L I A
1458 Xia et al.the long aliphatic chain of Lys still makes favorable contacts
with hydrophobic residues Val-27, Val-522, and Pro-2931,
thereby maintaining a strong interaction between the aA
helix and CDR-H1.
Compared with the highly conservative aromatic residues
in the binding region of HA and Fab-CDR-H2 discussed
above, we found that the binding interface between HA
and Fab-CDR-H1 exhibited relatively more variability in
amino-acid selection in HA. Hydrophobic residues were
usually required for site 522 to maintain the Fab binding.
However, the binding interface near site 562 required a
tightly packed hydrophobic environment. We found that
the V522I or I562V mutation could actually increase the
binding affinity by ~1 kcal/mol and ~0.5 kcal/mol, respec-
tively. A strong but nonspecific binding between HA and
antibody could be an important principle to consider in
designing vaccines with a broad neutralization.Asn-38 in group 2 HA1 may contribute
to the antibody neutralization escape
The molecular mechanism that prevents most group 2 HAs
(e.g., H3 and H7) from being neutralized by F10 or CR6261
is not fully understood. In previous studies, glycosylation at
position 381 on group 2 HAwas proposed as the main reason
for neutralization escape (13,14). However, we found that
two of the six subtypes in group 2 are not glycosylated at
position 381, yet are able to escape the neutralization.
That is, the glycosylation may not be the only mechanism
to explain the immunity escape of group 2 subtypes. We
investigated possible molecular mechanisms beyond the
glycosylation by searching the sequence diversity around
the HA-Fab binding interface. The sequences of all HA
subtypes were collected from the National Center for
Biotechnology Information Flu Database (Table 4). We
hypothesized that a residue site in HA would be importantBiophysical Journal 102(6) 1453–1461for the antibody’s escape from neutralization if the amino-
acid types of that specific site were diversified over different
groups but conserved within each group. That is, antibodies
could neutralize HA subtypes in one group with a specific
amino-acid type conserved at that site, whereas HA subtypes
in the other group might escape from the same antibodies
due to a different amino-acid type being conserved at the
same site. For site 381, His is a well-conserved residuewithin
group 1 (e.g., H1, H5, H2, H6, and H9), whereas Asn is
a conserved residue within group 2 (in four out of six
subtypes (H3, H7, H10, and H15)). Other sites, such as 401
and 382, are not fully conserved either across groups or
within individual groups, indicating that they may play a
less critical role in the neutralization (Table 4).
To confirm our hypothesis from the above sequence anal-
ysis and to reveal the atomic detail of the binding specificity,
we performed the FEP mutation for His-381 in our current
group 1 H5N1 HA to Asn-38, mimicking the conservative
amino acid in group 2 HA. The simulated FEP results
showed that the binding affinity between HA and Fab
decreased by 1.32 5 0.78 kcal/mol, which is an ~10-fold
increase in the dissociation constant (Kd) value. When we
compared the final structure with the WT, we found that
the two native hydrogen bonds (nitrogen atoms at the side
chain of His-381 to the hydroxyl group of Ser-30 or Gln-
64 in Fab) were broken by the mutation (Fig. 4). The loss
of side-chain hydrogen bonding was partially compensated
by waters entered in the binding interface, but no direct
contact was found between mutated Asn-381 and Fab.
Therefore, the H381N mutation weakened the interaction
between HA and Fab by breaking the hydrogen bonds
between HA1 and the antibody. However, it should be noted
that the binding affinity decrease of 1.32 5 0.78 kcal/mol
in the H381N mutation is not overwhelming, indicating
that antibody neutralization is a complicated process, and
that although this His-38 residue may be an important
FIGURE 4 Structural comparison of F10 nAb bound to H5 HA around
CDR-H2 due to H381N mutations (HA, green; nAb, cyan). The overall
complex is represented as cartoon and the residues at interaction face are
rendered with sticks. The side-chain hydrogen bonds between His-381/
Gln64 and His-381/Ser-30 (shown with yellow dashed line) are broken by
H381N mutation.
Influenza HA Antibody Binding Affinity Calculation 1459contributing factor, it is probably not the only factor (other
factors, such as glycosylation, may contribute as well
(13,14)). Indeed, several other group 1 subtypes that are
bound/neutralized by F10, such as H8 and H11, do not
have His at position 38, and instead have Gln or Ser, respec-
tively (13). Nevertheless, our FEP calculations indicate that
in addition to glycosylation, the existence of Asn at position
381 may also be an important contributing factor in neutral-
ization escape in group 2 HA subtypes.CONCLUSION
In this work, we performed rigorous FEP calculations to
estimate influenza antigen-antibody binding affinities (using
H5 HA and F10 Fab as a template) and study the character-
istics of antibodies with a broad neutralization capability
(such as F10 and CR6261). The simulated binding affinities
between HA and Fab were in excellent agreement with the
currently available experimental data. We identified several
key residues in the HA-Fab binding regions and further
examined them by means of in silico mutagenesis studies
to explore the molecular mechanism of HA-Fab binding.
We found that the stacking interaction of Trp-212 (HA)
and Phe-55 (Fab) is critical for strong binding between the
aA helix and the CDR-H2 of antibody. Our FEP simulations
suggest that either W212A in (HA side) or F55A (antibody
side) will cause a significant binding affinity decrease of
DDG > 4.0 kcal/mol (equivalent to an ~1000-fold increase
in the binding dissociation constant Kd). In addition, neigh-
boring hydrophobic residues were also required to preserve
a stable hydrophobic network around the aromatic side
chains. Furthermore, we observed more general hydro-
phobic interactions between HA and the CDR-H1 of Fab.
The HA residue sites 522 and 562 appeared to be more
tolerable with various hydrophobic mutations with similar
binding ability as the WT, which could explain the wide
neutralization of Fabs among all group 1 subtypes. In
addition, we found that the V522I and I562V substitutionscould increase the binding affinity by ~1 kcal/mol and
~0.5 kcal/mol, respectively, which potentially could be used
as a way to improve the efficiency of current antibodies.
In addition to the hydrophobic interactions, the hydrogen
bonding between His-381 and Ser-30/Gln-64 were also
found to be important for antibody neutralization. When
His-381 was mutated to group 2-like Asn-381, two hydrogen
bonds were lost, substituted by hydration around Asn-381 in
between the HA and the Fabs, with a net decrease of
~1.3 kcal/mol in binding affinity. This could be another
important contributing factor for the neutralization escape
in group 2 subtypes, in addition to the glycosylation.
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